Search
Search Constraints
You searched for: Record Type Journal Article Author/Creator Suquillo, DanielaLimit your search
- Suquillo, Daniela [remove] 1
- 616.994 1
- ACCE analytical validity, clinical validity, clinical utility, ethical, legal, and social implications -- ACS American Cancer Society -- ADC apparent diffusion coefficient -- AI artificial intelligence -- AIB1 coactivator amplified in breast cancer 1 -- AJCC American Joint Committee on Cancer -- ACR American College of Radiology -- anti-CTLA-4 anti-cytotoxic t-lymphocyte-associated protein 4 -- anti-PD1 anti-programmed cell death protein 1 -- anti-PD-L1 anti-programmed cell death-1 ligand 1 -- AR androgen receptor -- ARFI Acoustic Radiation Force Impulse Imaging -- ASCO American Society of Clinical Oncology -- BCSC Breast Cancer Surveillance Consortium -- BI-RADS Breast Imaging-Reporting and Data System -- BMI body mass index -- BPx breast physical examination -- BCS breast cancer screening -- CAD computer-aided detection -- CAFs cancer-associated fibroblasts -- CBE clinical breast examination -- CDC Centers for Disease Control and Prevention -- CEM contrast-enhanced mammography -- CE-MRI contrast enhanced-mri -- Chi3L1 chitinase 3-like 1 -- CSCs cancer stem cells -- ctDNA circulating tumor DNA -- CTS clinical treatment score -- CTX Chemotherapy -- CXCL4 chemokine (c-x-c motif) ligand 4 -- DBT digital breast tomosynthesis -- DCIS ductal carcinoma in situ -- DNA deoxyribonucleic acid -- DITI digital infrared thermography imaging -- DOT diffuse optical tomography -- DW-MRI diffusion weighted-MRI -- ECIBC european breast guidelines of the european commission initiative on breast cancer -- EGFR epidermal growth factor receptor -- EMT epithelial to mesenchymal transition -- EORTC European Organization for Research and Treatment of Cancer -- EPclin® endopredict clinical® -- ER+/- estrogen/estradiol receptor positive/negative -- EREs estrogen response elements -- ERRs α/β/γ estrogen-related receptors α/β/γ -- ESMO European Society for Medical Oncology -- EXET extended endocrine trial -- EXOs Exosomes -- FES 16α-18F-fluoro-17β-estradiol -- FDA Food and Drug Administration -- FDG Fluorodeoxyglucose -- FDS Fiberoptic ductoscopy -- FFA Free Fatty Acids -- FFDM full-field digital mammography -- GEP/S gene expression profiling/signatures -- GLOBOCAN Global Cancer Observatory -- HbT hydrogen breast test -- HDA1 histone deacetylase 1 -- HER1/2/3 +/- human epidermal growth factor receptor 1/2/3 positive/negative -- HR+/- hormone receptor positive/negative -- HT hormonal therapy -- IDC invasive ductal carcinoma -- IDO indoleamine 2, 3-dioxygenase -- IHC Immunohistochemistry -- IHC4 Immunohistochemical 4 -- IL Interleukin -- IoT internet of things -- IR InfraRed -- LCIS lobular carcinoma In Situ -- LN+/- lymph-nodes positive/negative -- mAbs monoclonal antibodies -- MHC-I major histocompatibility complex i -- MINDACT microarray in node-negative disease may avoid chemotherapy trial -- miRNAs MicroRNAs -- ML Machine Learning -- MRE magnetic resonance elastography -- MRI magnetic resonance imaging -- MSCs mesenchymal stem cells -- mTOR mammalian target of rapamycin -- NADH reduced nicotinamide adenine dinucleotide -- NCCN National Comprehensive Cancer Network -- N-CoR nuclear receptor co-repressor -- NmU Neuromedin U -- OCT Optical Coherence Tomography -- PET/CT positron emission tomography/computed tomography -- PGC1α/1β peroxisome proliferator-activated receptor gamma co-activator 1α/1β -- PPARγ peroxisome proliferator-activated receptor-γ -- PR+/- progesterone receptor positive/negative -- RASTER microarRAy-prognoSTics-in-breast-cancER -- ROI region of interest -- ROS reactive oxygen species -- RTK receptor tyrosine kinase -- SBI Society of Breast Imaging -- SEER surveillance, epidemiology and end results -- SG St. Gallen International Breast Cancer Conference -- SND spontaneous nipple discharge -- SoC system-on-chip -- STAT3 signal transducer and activator of transcription 3 -- StO2 oxygen saturation -- TA-MUC1 tumor-associated transmembrane glycoprotein mucin 1 -- 99mTc-MIBI technetium-99m sestamibi -- TFF1 Trefoil Factor 1 -- TMA tissue microarray -- TME tumor microenvironment -- TNM tumor, node and metastasis -- TransATAC trial trans arimidex, tamoxifen, alone or in combination trial -- UCPs uncoupling proteins -- US United States -- USPSTF U.S. Preventive Services Task Force -- VEGF vascular endothelial growth factor -- YAP yes-associated protein 1
- Breast cancer -- Screening -- Diagnosis -- Tools -- Mammography -- Biopsy -- Genetic profiling -- Artificial intelligence 1
- Hematology -- Periodicals 1
- Oncology -- Periodicals 1